Recent content by Health Master

This chart is looking similar to AMC, (when I predicted back in Feb at $7, went to $70. Now SENS (Senseonics Holdings Inc.), at $4.5, can go to $10. Positive Moving avg., Current Ratio, Closing action, Technical Events, Corp. Governance + Chart formation. $10 Price Target.

[FNKO] Funko, Inc., > 50% Undervalued, [$29] Target Price Potential Non Fungible Token (NFT) collectible Moving averages indicating higher ⬆ Market Cap. to Operating Cashflow discounted Price to Sales low comparable Closing higher prices Increasing volume spikes ⬆ Value, Growth, & Momentum top...

[CSCW] Color Star Technology Co., Ltd- Absolute Deep Value, > 80% Undervalued [$5 Target Price] Summary Details: +10/50 Day moving averages Current Ratio, very liquid Price/Cash undervalued Price/Sales fractional Enterprise Value/ Marketcap discount Closing prices positive Large increase in...

$3 PFMT, Current Ratio healthy liquidity, 6M Rounding Bottom (Cup & Handle) technical chart pattern, Price to Sales comparable of even 1X Sales = $3 [PFMT].

(DPZ) Dominos Pizza, Overvalued ($231-$279) Price Target Summary Details: Nutritional Diet- Unhealthy long term outcome 10/50 Day moving averages down Growth Rate/ Price Earnings excessive Price to Cash per share overpriced Downward earnings estimates surprise Overbought Stochastics 13D...

[YRD] Yiren Digital: 10day MA+, Enterpise Value to Market Cap.+, Short Ratio+, MACD↑, Chart Base built, Insiders & 13F filers+, , 86% undervalued $40 Fair Value (https://simplywall.st/stocks/us/diversified-financials/nyse-yrd/yiren-digital#valuation…), FV of $124 (YahooPremium) 162% Est...

Definitely undervalued! 10/50 day Moving Averages positive, Growth rate to P/E attractive, Price to Cash low comparable, Market Cap. to Operating Cashflow excellent, Price to Sales a bargain, Zack Rank's = A+, great Corporate Governance, MACD up, Insiders & 13F filers positive outlook on...

After conducting the research, I invested in and made over 200% on (XTLB) & (EYES), short % of float has been reduced to less than 1% of outstanding shares short currently. Now investing in (XENT), has a short % of float of 6x larger (6.25%), total of 1,050,000 shares short, so may see an even...

Ears, Nose, Throat Devices Market to reach $26BB, bio-absorbable devices such as Propel & Sinuva fastest growing segment. https://www.acumenresearchandconsulting.com/ear-nose-throat-ent-devices-market (XENT) capturing 5% of market realize $1.3BB in revenues/ 32MM Shares = 40$ per share in...

Allergic Rhinitis Market with the cumulative impact of COVID-19 expected to reach 5 BB...

50 Day MA positive, Enterprise Value/Market Cap attractive, EPS surprise of 400%, Corporate Governance 90% (ISS), MACD positive, Stochastics oversold, Bullish rounding bottom 1yr formation, 13F Put/Call Ratio improvement.

(CDXC) ChromaDex, Key products, Tru Niagen and Niagen, have shown promising growth with diminishing impact of COVID-19 following availability of vaccines, prospect of these products are likely to get boosted. Chromadex Corp Achieves Reduction In Recovery In Mild To Moderate Covid-19 patients...

(EARS) Altamira Medica advancing the testing of nasal spray for use in the protection against infections from airborne viruses such as SARS-CoV-2. Single dose AM-301 is administered for allergy management. (EARS) focuses on neurology, rhinology and allergy and CNS disorders.

(SIFY) Blackstone investment valuation at $1.2BB/ 179MM s/o = $6.7 (AEI) $45MM Earnings turnaround, Biotech. (MRM) Overallotment $15 per share, Preventative Medicine. (XTLB) Lupus, Sjogren's, Anemia FDA approval?

$1 Secondary Offering: If profitable today, take some off the table. I first bought at $2.50 and made 200% today! Keep in mind: Second Sight Medical Products previously conducted a Secondary Offering of $1 per share, Employees Layoffs & Brodsky & Smith LLC investigation of breach of fiduciary...